Notably, STAT3 mutations were identified in 12/30 (40%) of these cases, and the distribution of solid tumors between STAT3-mutated and wild-type LGLL was not different in this work [14]. This evidence concerns the gene STAT3 and T-cell large granular lymphocyte leukemia.